New hope for women with resistant ovarian cancer: drug combo trial launches
NCT ID NCT05551507
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study tests a new drug called IN10018 combined with standard chemotherapy for women with a type of ovarian cancer that no longer responds to platinum-based treatments. About 150 adults will take part to see if the combination is safe and shrinks tumors. The goal is to find a better way to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATINUM-RESISTANT OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Obstetrics and Gynecology Hospital of Zhejiang University
RECRUITINGHangzhou, China
Contact
-
Anyang Cancer Hospital
RECRUITINGAnyang, China
Contact
-
Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College
RECRUITINGBeijing, China
Contact
-
Fujian Cancer Hospital
RECRUITINGFuzhou, China
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, China
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, China
Contact
-
Tianjin Cancer Hospital
RECRUITINGTianjin, China
Contact
Conditions
Explore the condition pages connected to this study.